Collegium Pharmaceutical (COLL)
NASDAQ:COLL
Holding COLL?
Track your performance easily

Collegium Pharmaceutical (COLL) Financial Statements

460 Followers

Collegium Pharmaceutical Financial Overview

Collegium Pharmaceutical's market cap is currently ―. The company's EPS TTM is $2.579; its P/E ratio is 15.03; Collegium Pharmaceutical is scheduled to report earnings on November 6, 2024, and the estimated EPS forecast is $1.60. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 145.28M$ 144.92M$ 149.75M$ 136.71M$ 135.55M
Gross Profit$ 90.81M$ 91.46M$ 94.63M$ 80.31M$ 111.29M
EBIT$ 29.10M$ 53.96M$ 65.99M$ 49.55M$ 77.12M
EBITDA$ 66.58M$ 90.76M$ 102.85M-$ 117.64M
Net Income Common Stockholders$ 19.61M$ 27.71M$ 31.94M$ 20.63M$ 13.01M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 271.63M$ 318.05M$ 310.55M$ 304.56M$ 325.47M
Total Assets$ 1.05B$ 1.11B$ 1.14B$ 1.18B$ 1.21B
Total Debt$ 559.46M$ 629.99M$ 674.28M$ 718.39M$ 762.35M
Net Debt$ 287.83M$ 311.94M$ 363.74M$ 413.82M$ 436.88M
Total Liabilities$ 836.80M$ 892.08M$ 947.88M$ 998.71M$ 1.01B
Stockholders Equity$ 216.58M$ 222.17M$ 195.43M$ 178.87M$ 200.81M
Cash Flow-
Free Cash Flow$ 67.13M$ 61.37M$ 73.17M-$ 99.67M
Operating Cash Flow$ 67.40M$ 61.94M$ 73.34M$ 74.02M$ 99.72M
Investing Cash Flow$ -8.91M$ -18.13M$ -25.10M$ -3.82M$ -41.72M
Financing Cash Flow$ -114.21M$ -54.15M$ -67.83M$ -95.41M$ -45.24M
Currency in USD

Collegium Pharmaceutical Earnings and Revenue History

Collegium Pharmaceutical Debt to Assets

Collegium Pharmaceutical Cash Flow

Collegium Pharmaceutical Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis